BioCentury | Oct 17, 2020
Translation in Brief

SARS-CoV-2 infects brain choroid plexus, compromises CSF-blood barrier; plus Passage’s GM1 gangliosidosis gene therapy, a new COVID-19 reporter and more

...and half-life of biologicsA team led by University of Oslo...
...la Recherche Medicale (INSERM) QIMR Berghofer Medical Research Institute University of Oslo Angiotensin-converting...
BioCentury | May 26, 2020
Distillery Therapeutics

Blocking flu with phage capsid nanoparticles

...Berlin, Germany email: hackenbe@fmp-berlin.de Claire Quang Leibniz Research Institute for Molecular Pharmacology Humboldt University of Berlin Free University of Berlin University of Oslo Influenza...
BioCentury | Feb 6, 2019
Distillery Therapeutics

Cancer

...Jin, University of Oslo, Oslo, Norway email: yang.jin@ibv.uio.no CONTACT: Fahri Saatcioglu, same affiliation as above email: fahris@ibv.uio.no Claire Quang University of Oslo Endoplasmic...
BioCentury | Jan 28, 2019
Preclinical News

Unfolded protein response activates MYC in prostate cancer

...Mitochondrial Dysfunction with Antitumor T Cell Activity" ). In a Nature Communications article published Thursday, University of Oslo...
...1; MYC (c-Myc) - v-myc myelocytomatosis viral oncogene homolog; XBP1 - X-box binding protein 1 Sandi Wong University of Oslo University...
BioCentury | Nov 30, 2018
Targets & Mechanisms

Adhesion targets emerge at ASH 2018

...NKG2C-expressing NK cell therapy, in Phase I testing for AML and ovarian cancer. In April, University of Oslo...
...NYSE:PFE), New York, N.Y. University Children’s Hospital Tübingen, Tübingen, Germany University of Minnesota, Minneapolis, Minn. University of Oslo...
...Therapeutics Inc. Genmab A/S Memorial Sloan Kettering Cancer Center Miltenyi Biotec GmbH Nationwide Children's Hospital Nordic Nanovector ASA Pfizer Inc. University of Minnesota University of Oslo CD37 CD83 Killer...
BioCentury | May 9, 2018
Translation in Brief

The fate of NK cells

...NK cells age and reach a terminal differentiation state. Malmberg is a professor at the University of Oslo...
...work -- how they differentiate and tune their functionality based on receptor input.” Karl-Johan Malmberg, University of Oslo...
...retargeting driven by chimeric antigen receptors.” Cancer Immunology Research (2018) Jaime de León, Staff Writer Fate Therapeutics Inc. University of Oslo CD19 CD57 Killer...
BioCentury | Jan 18, 2018
Translation in Brief

A notch for tankyrase

...Eisai Co. Ltd. (Tokyo:4523) and the now-defunct Odin Therapeutics A/S, a 2010 spinout from the University of Oslo...
BioCentury | Mar 16, 2017
Product R&D

Neo wave

...Life Sciences Partners; Versant Ventures Vaccibody A/S Unnamed Plasmid DNA vaccine encoding neoantigens Cancer Preclinical University of Oslo...
BioCentury | Jan 6, 2017
Emerging Company Profile

Gobbling globulins

...University collaborators: University of Pennsylvania , The Jackson Laboratory , Brigham and Women’s Hospital , University of Oslo...
BioCentury | Aug 17, 2015
Finance

Medigene remade

...cell vaccines engineered to induce T and natural killer cell responses against cancer antigens. The University of Oslo...
...Abingdon, U.K. Medigene AG (Xetra:MDG1), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd. (Taiwan:1734), Taipei City, Taiwan University of Oslo...
Items per page:
1 - 10 of 23
BioCentury | Oct 17, 2020
Translation in Brief

SARS-CoV-2 infects brain choroid plexus, compromises CSF-blood barrier; plus Passage’s GM1 gangliosidosis gene therapy, a new COVID-19 reporter and more

...and half-life of biologicsA team led by University of Oslo...
...la Recherche Medicale (INSERM) QIMR Berghofer Medical Research Institute University of Oslo Angiotensin-converting...
BioCentury | May 26, 2020
Distillery Therapeutics

Blocking flu with phage capsid nanoparticles

...Berlin, Germany email: hackenbe@fmp-berlin.de Claire Quang Leibniz Research Institute for Molecular Pharmacology Humboldt University of Berlin Free University of Berlin University of Oslo Influenza...
BioCentury | Feb 6, 2019
Distillery Therapeutics

Cancer

...Jin, University of Oslo, Oslo, Norway email: yang.jin@ibv.uio.no CONTACT: Fahri Saatcioglu, same affiliation as above email: fahris@ibv.uio.no Claire Quang University of Oslo Endoplasmic...
BioCentury | Jan 28, 2019
Preclinical News

Unfolded protein response activates MYC in prostate cancer

...Mitochondrial Dysfunction with Antitumor T Cell Activity" ). In a Nature Communications article published Thursday, University of Oslo...
...1; MYC (c-Myc) - v-myc myelocytomatosis viral oncogene homolog; XBP1 - X-box binding protein 1 Sandi Wong University of Oslo University...
BioCentury | Nov 30, 2018
Targets & Mechanisms

Adhesion targets emerge at ASH 2018

...NKG2C-expressing NK cell therapy, in Phase I testing for AML and ovarian cancer. In April, University of Oslo...
...NYSE:PFE), New York, N.Y. University Children’s Hospital Tübingen, Tübingen, Germany University of Minnesota, Minneapolis, Minn. University of Oslo...
...Therapeutics Inc. Genmab A/S Memorial Sloan Kettering Cancer Center Miltenyi Biotec GmbH Nationwide Children's Hospital Nordic Nanovector ASA Pfizer Inc. University of Minnesota University of Oslo CD37 CD83 Killer...
BioCentury | May 9, 2018
Translation in Brief

The fate of NK cells

...NK cells age and reach a terminal differentiation state. Malmberg is a professor at the University of Oslo...
...work -- how they differentiate and tune their functionality based on receptor input.” Karl-Johan Malmberg, University of Oslo...
...retargeting driven by chimeric antigen receptors.” Cancer Immunology Research (2018) Jaime de León, Staff Writer Fate Therapeutics Inc. University of Oslo CD19 CD57 Killer...
BioCentury | Jan 18, 2018
Translation in Brief

A notch for tankyrase

...Eisai Co. Ltd. (Tokyo:4523) and the now-defunct Odin Therapeutics A/S, a 2010 spinout from the University of Oslo...
BioCentury | Mar 16, 2017
Product R&D

Neo wave

...Life Sciences Partners; Versant Ventures Vaccibody A/S Unnamed Plasmid DNA vaccine encoding neoantigens Cancer Preclinical University of Oslo...
BioCentury | Jan 6, 2017
Emerging Company Profile

Gobbling globulins

...University collaborators: University of Pennsylvania , The Jackson Laboratory , Brigham and Women’s Hospital , University of Oslo...
BioCentury | Aug 17, 2015
Finance

Medigene remade

...cell vaccines engineered to induce T and natural killer cell responses against cancer antigens. The University of Oslo...
...Abingdon, U.K. Medigene AG (Xetra:MDG1), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd. (Taiwan:1734), Taipei City, Taiwan University of Oslo...
Items per page:
1 - 10 of 23